TCI-31 LIFELONG OVULATION TESTER
Dec 2001
61d
Tci New York has submitted 1 FDA 510(k) premarket notifications since 2001, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Radioimmunoassay, Luteinizing Hormone . Use the specialty filter in the sidebar to narrow results.